… This study investigated the modulatory effects of a fully human IgG1 monoclonal antibody
directed against phosphorylcholine (PC-mAb) on myocardial remodeling and cardiac function …

… Abs against phosphorylcholine (anti-PC) and Abs against malondialdehyde (anti-MDA) may
be protective in chronic inflammation, like atherosclerosis and cardiovascular disease. It is …

… mice that a specific clone of IgM autoantibodies against phosphorylcholine, termed E06 or
T15 … IgM phosphorylcholine antibodies are associated with an increased risk of cardiovascular …

… anti-phospholipid autoantibody levels in patients with antiphospholipid syndrome, …
cardiovascular diseases. However, the underlying mechanisms of anti-phospholipid autoantibodies …

… -G1 antibody against phosphorylcholine on oxidized phospholipids preserves coronary flow
… to assess the efficacy of phosphorylcholine-targeted therapy on coronary artery function and …

… anti-cardiolipin antibody and IgG antiphosphoryl choline) in (Atherosclerotic cardiovascular
… correlation between IgG Antiphosphoryl choline with IgM anticardiolipin antibody. Whereas, …

… Previous data has shown that natural IgM anti-PC protect against cardiovascular disease.
We aimed to develop a monoclonal PC IgG antibody with anti-inflammatory and anti-…

… The natural mouse monoclonal antibody E06 recognizes the phosphocholine (PC) headgroup
of oxidized, but not native, phospholipids. Subtle conformational changes in the PC head …

… Phosphorylcholine (PC) is an immunogenic epitope in the … patients exhibit elevated levels
of anti-PC and this antibody … phosphorylcholine (anti-phosphorylcholine IgG) in patients with …

… autoantibodies anti-phoshorylcholine (anti-PC) and antimalondialdehyde (anti-MDA) and
their prevalence in cardiovascular disease (CVD) … on human anti-phosphorylcholine (anti-PC) …